Jan 13 (Reuters) - Lantheus Holdings Inc LNTH.O:
LANTHEUS TO ACQUIRE LIFE MOLECULAR IMAGING FOR AN UPFRONT PAYMENT OF $350 MILLION TO ACCELERATE INNOVATION FOR PATIENTS IN THE GROWING ALZHEIMER’S DISEASE RADIODIAGNOSTIC MARKET
LANTHEUS HOLDINGS INC - TRANSACTION EXPECTED TO BE ACCRETIVE TO ADJUSTED EPS WITHIN 12 MONTHS
LANTHEUS HOLDINGS INC - DEAL INCLUDES $350 MILLION UPFRONT AND UP TO $400 MILLION IN EARN-OUT PAYMENTS
Source text: ID:nGNX70rGrk
Further company coverage: LNTH.O
((Reuters.Briefs@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.